Activating Compound | Comment | Organism | Structure |
---|---|---|---|
cGMP | - |
Rattus norvegicus |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
DT-2 peptide | - |
Rattus norvegicus | |
KT5823 | effect of KT5823 is abolished in the presence of the nonselective cyclic nucleotide PDE inhibitor 3-isobutyl-1-methylxantine or the selective cGMP-PDE5 inhibitor sildenafil | Rattus norvegicus |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Rattus norvegicus | - |
- |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
myocyte | adult rat ventricular, and caridac | Rattus norvegicus | - |
Synonyms | Comment | Organism |
---|---|---|
PKG | - |
Rattus norvegicus |
Cofactor | Comment | Organism | Structure |
---|---|---|---|
ATP | - |
Rattus norvegicus |
General Information | Comment | Organism |
---|---|---|
malfunction | PKG inhibition also potentiates the effect of SNAP on global cGMP levels and fully blocks the increase in cGMP-PDE5 activity | Rattus norvegicus |
metabolism | cGMP-dependent protein kinase exerts a feedback control on cGMP concentration contributing to its intracellular compartmentation | Rattus norvegicus |
physiological function | cGMP-dependent protein kinase exerts a feedback control on cGMP concentration contributing to its intracellular compartmentation, negative feedback of PKG on sGC-cGMP signaling attributable to PDE5 activation, kinetics and overview. PKG inhibition decreases and PKG activation increases cGMP-gated current. PKG activation in adult cardiomyocytes limits the accumulation of cGMP induced by NO donors via PDE5 stimulation but increases that induced by natriuretic peptides | Rattus norvegicus |